participants, setting, methods: Five hundred and thirty women with recurrent miscarriage were included. Actual care was assessed with 23 guideline-based quality indicators (covering diagnostics, therapy and counselling) by calculating per indicator the percentage of women for whom the indicator was followed. Thereafter we did multilevel analyses, to relate the adherence to the indicator to determinants of women, professionals and hospitals.
Introduction
Recurrent miscarriage affects 1 -5% of all couples trying to conceive. Couples confronted with recurrent miscarriage often seek medical help to identify underlying risk factors for their recurrent loss and if possible, treatment (Musters et al., 2011) . Knowledge on diagnostics, therapy and counselling has been integrated into guidelines to facilitate patient care. However, adherence to the first Dutch guideline was extremely poor (Franssen et al., 2007) . No data are available about adherence to other international recurrent miscarriage guidelines, in clinical practice (Royal College of Obstetricians and Gynaecologists (RCOG), 2011). Applying new evidence from clinical research into daily medical clinical practice is difficult, about 40% of patients do not receive appropriate care and about 20 -25% of care provided is not needed or is potentially harmful (McGlynn et al., 2003; Mourad et al., 2008; van Peperstraten et al., 2010) .
Recent evidence on diagnostics in recurrent miscarriage has been incorporated in revised and newly published clinical guidelines (European Society of Human Reproduction and Embryology (ESHRE) 2006; Dutch Society of Obstetrics and Gynaecology (NVOG), 2007; National Guideline Clearinghouse (NGC) 2009; RCOG, 2011) . Especially for diagnostic procedures like parental karyotyping and thrombophilia screening, some major changes took place in the Dutch guideline (NVOG, 2007) . It is now recommended to perform parental karyotyping only in couples with an increased risk of chromosome abnormalities (.2.2%), based on the model for selective karyotyping (Franssen et al., 2005) . Instead of standard screening for inherited thrombophilia, the guideline now contains the advice to perform screening only in high-risk women, i.e. women with a history of thrombosis, or in women with a first-degree family member with thrombosis and inherited thrombophilia. The recommendation to test homocysteine and antiphospholipid antibodies in all women did not change in the revised guideline. The question thus arises: do professionals adhere to the revised guidelines and what determines whether they adhere to them or not? Previous research on IUI guidelines showed a variety of factors at patient and hospital levels that could explain differences in guideline adherence . Such factors-i.e. determinants-are a key step towards improvement of guideline adherence.
The aims of our study were to assess actual quality of care in couples with recurrent miscarriage and to analyse whether variation in this care relates to determinants at the level of the woman, the professional or the hospital.
Methods

Study design and population
We performed a retrospective cohort study in nine departments of Obstetrics and Gynaecology in the Netherlands. Two university hospitals, four nonuniversity teaching hospitals and three non-university non-teaching hospitals participated in the study. Recurrent miscarriage was defined according to the National Guideline Clearinghouse (NGC) guideline as a history of two or more preceding miscarriages (NGC, 2009) .
Women with recurrent miscarriage were identified from hospital financial registries and clinical genetics registries. We then scanned the medical files of all women who visited the departments in 2006 for a miscarriage for their obstetric history. Patients were eligible for the study if they had experienced one or more miscarriages before their actual miscarriage in 2006. In order to include equal numbers from university and non-university hospitals; in the two largest non-university hospitals with a very high number of women with recurrent miscarriage, we only included every third woman who visited the clinic for recurrent miscarriage, to provide a reliable reflection of the annual population.
Data collection
Actual care
To measure guideline adherence we previously developed a set of 23 quality indicators for recurrent miscarriage (van den Boogaard et al., 2010) . A quality indicator is an instrument to measure quality of care and is defined as the number of patients who received appropriate care divided by the number of patients who should have received this care (Donabedian, 1988; Lawrence and Olesen, 1997) . The complete set of quality indicators covers all aspects of diagnostics, therapy and counselling. Data on diagnostics, therapy and counselling were obtained through medical records and additional questionnaires were sent to the patients. These additional questionnaires were used to gain background information, for example to determine the exact a priori risk for chromosomal abnormalities. Quality of actual care in recurrent miscarriage was expressed as the percentage of patients who received care according to the evidence-based Dutch guideline, adopted by the NGC (NGC, 2009).
Determinants
Potential characteristics that might influence care, so-called determinants, were collected at the level of the woman, the professional and the hospital. Woman's determinants were extracted from medical records and questionnaires. These included maternal age at the time of first hospital visit at diagnosis, history of no children versus at least one live birth, number of preceding live births, number of preceding miscarriages and socio-economic status as indicated by income (below average, average, above average). We extracted data on year income via the postal codes related incomes, using the Central Office for Statistics (Statistics Netherlands (CBS)). The attending professional was registered for each woman. Determinants of the professional-based on literature and basic personal characteristicswere collected through questionnaires: age, sex, function (consultant or registrar), subspecialization in recurrent miscarriage, i.e. doctors who run a recurrent miscarriage clinic (yes or no), and annual number of women seen with recurrent miscarriage. Hospital determinants were defined as type of hospital (university, non-university teaching or non-university nonteaching), number of gynaecologists and number of couples with recurrent miscarriage seen annually.
Statistical analysis
Actual care was expressed as a percentage of adherence to an indicator. For each indicator, the overall adherence and the inter-hospital range of adherence were determined.
To assess the influence of the determinants at the level of the woman, the professional and the hospital on actual care, both univariable and multilevel regression analyses were performed. Professionals are clustered within hospitals and one professional usually treats more than one patient. For this reason, actual care in an individual woman cannot be interpreted without considering the professional and hospital visited by this woman (Hargraves et al., 2001) . Therefore, after univariable analysis, we performed multilevel analyses to correct for clustering. Univariable logistic regression analysis was applied to examine the associations between individual determinants at the level of the woman, professional or hospital (independent variables) on the one hand, and adherence to the indicators (dependent variables) on the other hand. Variables with P-values ,0.15 were eligible for multilevel regression analysis. Prior to the multilevel regression analysis, we performed correlation analysis to evaluate co-linearity between all possible influencing factor variables. Those variables with high correlation coefficients (.0.4) were excluded from further analysis. We included one parameter from the correlated pair of set. For the multilevel analysis, determinants with P-values ,0.05 were considered significant. The Statistical Program for the Social Sciences (SPSS 16.0 for Windowsw, SPSS, Inc., Chicago, IL, USA) and R software (R 2.10.0)(lme 4) were used for the analyses.
Results
We included 530 women in the study. Two hundred and eighteen questionnaires (41%) were returned fully completed. The questionnaires were complementary to the medical files, so all 530 patients could be included in the analysis with adequate datasets. The characteristics of the women at the time of their first consultation are listed in Table I . The mean (SD) maternal age at the time of presentation was 34.1 (5.3) years. The number of preceding miscarriages varied from 2 to 8
Guideline adherence in recurrent miscarriage (median 2). More than half of the women had at least one live birth (n ¼ 315, 59%). Of all women who received diagnostic work-up, 4 of 247 (1.6%) were diagnosed with antiphospholipid syndrome and 15 of 341 (4.4%) had a parental structural chromosome abnormality, 7 being clinically relevant (2.1%). Clinical relevance was judged by the clinical geneticist involved according to available evidence on impact of this particular structural chromosome abnormality on health or reproductive outcomes. Eighteen of 208 (8.7%) had hyperhomocysteinaemia. Fetal chromosome testing was not carried out. In the Dutch guideline 2007, as well as in the ESHRE guideline 2006, it is recommended not to perform fetal chromosome testing as routine care, because results will not alter clinical outcome. This means that fetal karyotype-for the indication of recurrent miscarriage-is only tested within the setting of clinical studies. During our inclusion period, no such study was available in the participating centres. This explains why we did not find any case in which fetal chromosome testing was carried out.
The remaining 501 (94.5%) women were diagnosed with unexplained recurrent miscarriage. Regarding the professionals, 117 professionals were involved in patient's care at first visit: 69 gynaecologists with various subspecializations, 41 registrars and 7 fertility doctors (Table II) . All professionals answered the questionnaire. Of the nine participating hospitals, two were university hospitals, four non-university teaching hospitals and three non-university non-teaching hospitals. The median number of gynaecologists per hospital was eight (range 4 -26), the median annual number of women with recurrent miscarriage seen in each hospital was 55 (range 27-222).
Actual care
The actual care per indicator and the variation between hospitals are described in Table III . A large variation between hospitals was found as reflected by the range of adherence to one indicator. A high or low adherence was not consistent per hospital. In other words, each hospital had its stronger and weaker points.
Of the indicators concerning diagnostics, the highest adherence was seen for the indicator on lifestyle. In 67% (range 7-97%) of the women, the doctors reported history on lifestyle, followed by reporting on history of thrombophilia in 61% (range 4-77%). Thrombophilia screening was performed in 249 (47%) women. Out of these 249 women, 4 of them were at high risk and 245 at low risk for inherited thrombophilia defects based on their own medical history and their family history. Overall, adherence to selective thrombophilia screening was 54% (284 of 530, range 36-79%), i.e. four high-risk women were tested and 280 low-risk women were not tested. Selective karyotyping was performed in 50% (range 39-60) of the couples, with the same percentages for high-and low-risk couples. For all indicators on diagnostics, 6 out of 11 showed an adherence ,50%.
With regard to therapy, the highest adherence was seen for withholding immunotherapy and for providing supplement vitamins in case of low vitamin levels, with an overall indicator performance of 100% in all hospitals. In 2% of the couples experimental treatment was prescribed outside the setting of a randomized clinical trial. The prescribed treatment consisted of aspirin, heparin or progesterone. This was the lowest adherence, as within the field of therapy all measurable indicators scored above 50%.
Regarding counselling, the advice to quit smoking (30%, range 0-100%) and advice on weight loss (14%, range 0-56%) showed large variation between hospitals. Three out of four measurable indicators on counselling showed an adherence ,50%. The advice to use folic acid preconceptionally and Tender Loving Care could not be measured adequately, since their performance was not documented in the medical files.
Determinants
Of the 23 indicators, 14 showed variation between the hospitals and had at least 10 women per hospital. These 14 indicators were eligible for a multilevel analysis. No determinants were found for the indicators 'report maternal age at the time of the second miscarriage', record family history of thrombophilia', 'advise to quit smoking' and 'advise weight loss'. For the other 10 indicators, significant determinants for lower adherence to the indicator were found, summarized in Table IV . Professionals are advised to ask about life style in all women, which was the indicator on diagnostics with the highest adherence, but it showed a wide inter-hospital range (67%, range 7-97%). Higher adherence to this indicator was seen in women with no live birth and in hospitals with a higher number of gynaecologists. The indicator with the widest inter-hospital range in adherence (33%, range 0-94%) was to report on a family history of recurrent miscarriages. Higher adherence was associated with a higher number of patients per professional, visiting a teaching hospital, and more women with recurrent miscarriage and gynaecologists per hospital.
Determinants could be defined for none of the indicators on therapy, and for one indicator on counselling. For the indicator to counsel women with unexplained recurrent miscarriage about their individual chances on reproductive outcome, lower number of preceding miscarriages, professionals without a subspecialization in recurrent miscarriage and lower number of gynaecologists per centre had a negative influence on adherence.
Discussion
In this study we measured the quality of care in couples with recurrent miscarriage according to a set of guideline-based quality indicators and related this to determinants related to women, professionals and hospitals. We were able to measure adherence to 21 of the 23 quality indicators for recurrent miscarriage. It appeared that adherence to the indicators was low and showed a wide variation between hospitals. For nine indicators we found that appropriate care was administered Guideline adherence in recurrent miscarriage in ,50% of women. Especially, diagnostic indicators showed a marginal adherence in hospitals, in which each hospital had its own profile in high and low adherence. Multilevel analyses did not show one clear determinant related to high adherence. Women with a higher maternal age were more likely to receive inappropriate care with regard to the indicators on standard diagnostic tests. On the other hand, women with lower maternal age were more often offered thrombophilia screening without any indication. If a woman had a history of at least one live birth, she was at risk for-incorrectly-not being offered standard diagnostic tests. The more miscarriages a woman had, the more likely that she received thrombophilia screening without indication. On the other hand, in women with a lower number of preceding miscarriages, professionals more often did not adhere to the guideline on selective parental karyotyping, screening for antiphospholipid antibodies and homocysteine, reporting BMI and discussing future reproductive chances. Professionals with a subspecialization in recurrent miscarriage performed better standard care (reporting the number of miscarriages, selective screening of thrombophilia factors, and discussion of individual chances on reproductive outcome, screening antiphospholipid antibodies and homocysteine), but also showed overuse of diagnostics in women at low risk for inherited thrombophilia. In other words, they were more inclined to offering all diagnostic tests available to all women presenting with recurrent miscarriage. Teaching hospitals showed better adherence to report on history of thrombophilia and family history of recurrent miscarriage. Hospitals with more gynaecologists performed better in determination of BMI and reporting family history of recurrent miscarriage. A higher number of patients per centre was not an unambiguous determinant. Our study underlines that, despite being evidence-based, new guidelines are not automatically adopted in clinical practice (Bero et al., 1998) . In other words, publication of new guidelines on recurrent miscarriage alone is not sufficient to implement new evidence and extra efforts besides publication are necessary (Grol, 1997 (Grol, , 2001 Franssen et al., 2007) . Since the revised international guidelines are mostly developed using the same AGREE instrument, it is unlikely to presume that actual care in other countries will differ from our results (AGREE, 2009). The high adherence in some hospitals underlines that improvement of adherence is possible. This is in line with the study on detection of barriers for adherence to the guideline of recurrent miscarriage, where gynaecologists agreed that complete adherence to the guideline was achievable (van den . Complete adherence would result in a substantial reduction of costs for recurrent miscarriage, since karyotyping and thrombophilia screening are the most expensive tests and are currently offered widely to couples without indication. Counselling on individual chances is not expensive, but could be very effective in the reduction of unnecessary visits for second and third opinions and performance of diagnostic tests without indications. Adherence to the previous guideline was also measured in the past and although low, showed better adherence to several indicators than the current study (Franssen et al., 2007) . For example the advice to perform screening for APS in all women-which did not change compared with the previous guideline-was done in 98% of women in the previous measurement, but only in 47% in our study. This difference is probably due to the different methods used. We took great care to detect all couples with recurrent miscarriage as these are the couples in whom the guideline should have been used. We included all patients who were registered as recurrent miscarriage patients, but we also checked all medical files of those who were registered as having had a 'sporadic' miscarriage during the study period. We assessed whether they had more preceding miscarriages or not. This way we could include those patients with a history of two or more miscarriages that were not registered as recurrent miscarriage patients by their doctors.
Franssen et al. asked professionals about their management, whereas we now measured guideline adherence at the level of the women with quality indicators (Franssen et al., 2007) . Professionals overestimate their own guideline adherence by 30 -40% compared with their actual adherence (Hrisos et al., 2009) . The use of indicators to measure quality of care is an important tool to measure actual adherence and due to the standardized development procedure of the indicators, we consider the current method precise and applicable in the future.
Despite the thorough procedure followed, some limitations to the study should also be discussed. First, the response rate of the questionnaires was 41%. The medical records were the sole source of information for all included women, since the outcome of the study is the actual care by professionals. The questionnaires were only used to complete background information, such as the exact a priori risk for chromosomal abnormalities (high or low risk). Since the questionnaire was complementary, the low response rate did not influence our primary or secondary outcome negatively. We therefore consider the low response not to be problematic. Secondly, the quality indicators are based on an evidence-based guideline and were defined as appropriate care. It is possible that guideline adherence, and therefore the score per quality indicator, is influenced negatively by disagreement of the professional with the guideline. Since the identification of barriers for guideline adherence did not reveal disagreement as a major reason for non-adherence, it is not likely that this was a major reason for difference in adherence in our study . The number of experts in this study was quite small. However the number of patients seen by these professionals was substantial (n ¼ 114). Within the field of implementation of guidelines, our study can best be compared with findings in the field of reproductive medicine. Literature about guidelines in the field of reproductive medicine also shows great variance in adherence to subfertility guidelines (Mourad et al., 2008; Haagen et al., 2010) . Visiting a non-teaching hospital, which was a negative determinant for reporting on history of thrombophilia and family history in our study, was also identified as a negative determinant for providing information in subfertility patients (Mourad et al., 2010) . Our other determinants were not described before and we can, therefore, not conclude whether these are unique for women with recurrent miscarriage or whether they might also influence quality of care in other groups of patients. Early pregnancy units are upcoming, especially in the UK (Habayeb and Konje, 2004) . By this means diagnostic procedures and treatment policies can be studied in the field of early pregnancy (Norrie et al., 2008) . The effect on quality of care has so far not been measured systematically. Three of the participating hospitals in our study worked with doctors with a subspecialization in recurrent miscarriage, which was in our study associated with a better performance of standard care but also with overuse of diagnostics on inherited thrombophilia.
Future research should focus on implementation of recent evidence in recurrent miscarriage care and therefore on improvement of guideline adherence. The identified determinants of care, together with the barriers for guideline adherence, are the basis for the development of an implementation strategy. Doctors should be reminded that higher maternal age and a lower number of preceding miscarriages are associated with a lower risk for chromosomal abnormalities, and this test should not be offered routinely. All women, including older women and/or women with a history of two miscarriages, should receive standard care such as screening for antiphospholipid syndrome and homocysteine.
A clear description in guidelines would be of benefit for the development of quality indicators, and subsequent measurement of actual care. 'For instance 'Tender Loving Care'-at present a non-measurable indicator-is not properly defined and adherence to this indicator can therefore not be measured (Musters et al., 2011) .
After introduction of the implementation strategy, guideline adherence should be compared with our current measurement. For future research on international guidelines adherence, the majority of the quality indicators used here will enable measurement of quality of care, since almost all indicators are compatible with the ESHRE Guideline and all of them are compatible with the NGC guideline (ESHRE, 2006; NGC, 2009 ).
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